Intellia Therapeutics
NTLA
NTLA
291 hedge funds and large institutions have $2.68B invested in Intellia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 122 increasing their positions, 77 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 283 → 291 (+8)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
30% less call options, than puts
Call options by funds: $21.1M | Put options by funds: $30.2M
Holders
291
Holding in Top 10
5
Calls
$21.1M
Puts
$30.2M
Top Buyers
| 1 | +$61M | |
| 2 | +$44.6M | |
| 3 | +$30.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$27.2M |
| 5 |
BlackRock
New York
|
+$26.8M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$9.34M | |
| 3 | -$8.73M | |
| 4 |
Millennium Management
New York
|
-$7.37M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$6.59M |